A risk-adapted treatment approach for mantle cell lymphoma
Speaking from the 2018 Society of Hematologic Oncology (SOHO) Annual Meeting in Houston, TX, Simon Rule, MD, from Plymouth University, Plymouth, UK, outlines the current standards of care for both you...
Author: VJHemOnc
Added: 09/21/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 21, 2018 Category: Cancer & Oncology Source Type: podcasts
The role of EZH2 mutations in MDS
EZH2 mutations are associated with a poor prognosis in myelodysplastic syndromes (MDS). In this video, recorded at the 2018 Society of Hematologic Oncology (SOHO) Annual Meeting in Houston, TX, Rashmi...
Author: VJHemOnc
Added: 09/21/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 21, 2018 Category: Cancer & Oncology Source Type: podcasts
Current landscape and future directions for lower-risk MDS treatment
Speaking from the 2018 Society of Hematologic Oncology (SOHO) Annual Meeting, held in Houston, TX, David Steensma, MD, of the Dana-Farber Cancer Institute, Boston, MA, discusses the current treatment ...
Author: VJHemOnc
Added: 09/21/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 21, 2018 Category: Cancer & Oncology Source Type: podcasts
Novel potent and selective FLT3 inhibitors
At the 2018 Society of Hematologic Oncology (SOHO) Annual Meeting, held in Houston, TX, Alexander Perl, MD, of the University of Pennsylvania, Philadelphia, PA, gives us an update on the recent develo...
Author: VJHemOnc
Added: 09/21/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 21, 2018 Category: Cancer & Oncology Source Type: podcasts
Identifying patient subgroups to improve outcome, resistance and toxicity in CAR T
CAR T-cells have the potential to revolutionize the field of hematological oncology, however despite impressive efficacy data from CAR T products, some patients develop resistance, have poor outcomes,...
Author: VJHemOnc
Added: 09/19/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 19, 2018 Category: Cancer & Oncology Source Type: podcasts
CAR T across hematological malignancies: trials to watch
Axicabtagene ciloleucel, an anti-CD19 CAR T-cell product, has shown impressive efficacy in diffuse large B-cell lymphoma already. In this video, recorded at the 2018 Society of Hematologic Oncology (S...
Author: VJHemOnc
Added: 09/19/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 19, 2018 Category: Cancer & Oncology Source Type: podcasts
ZUMA-1: updated data and future prospects
Speaking from the 2018 Society of Hematologic Oncology (SOHO) Annual Meeting held in Houston, TX, John Rossi, MS, from Kite Pharma Inc., Santa Monica, CA, presents updated data from the pivotal ZUMA-1...
Author: VJHemOnc
Added: 09/19/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 19, 2018 Category: Cancer & Oncology Source Type: podcasts
Are biomarkers the future in Non-Hodgkin Lymphoma?
Speaking at the 2018 Society of Hematologic Oncology (SOHO) Annual Meeting in Houston, TX, Nathan Fowler, MD, of The University of Texas MD Anderson Cancer Center, Houston, TX, discusses the increasin...
Author: VJHemOnc
Added: 09/19/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 19, 2018 Category: Cancer & Oncology Source Type: podcasts
OPTIMISMM: benefits of a new triplet therapy for MM patients relapsing on lenalidomide
Meletios Dimopoulos, MD, of the University of Athens School of Medicine, Athens, Greece, gives an overview of the OPTIMISMM trial (NCT01734928) at the 2018 Society of Hematologic Oncology (SOHO) Annua...
Author: VJHemOnc
Added: 09/19/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 19, 2018 Category: Cancer & Oncology Source Type: podcasts
Imaging modalities and treatment breakthroughs in myeloma bone disease
In this interview, recorded at the 2018 Society of Hematologic Oncology (SOHO) Annual Meeting in Houston, TX, Meletios Dimopoulos, MD, of the University of Athens School of Medicine, Athens, Greece, g...
Author: VJHemOnc
Added: 09/19/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 19, 2018 Category: Cancer & Oncology Source Type: podcasts
How reliable is NGS in diagnosing AML?
Christopher Gibson, MD, of Dana-Farber Cancer Institute, Boston, MA, discusses the reliability of next-generation sequencing (NGS) at the 2018 Society of Hematologic Oncology (SOHO) Annual Meeting, he...
Author: VJHemOnc
Added: 09/19/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 19, 2018 Category: Cancer & Oncology Source Type: podcasts
How HOPA plays a crucial role as a teaching platform for healthcare professionals
From the 2018 Hematology/Oncology Pharmacy Association (HOPA) Annual Conference, held in Denver, CO, Patrick Kiel, PharmD, BCOP, BCPS, of Indiana University Simon Cancer Center, Indianapolis, IN, deli...
Author: VJOncology
Added: 08/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 29, 2018 Category: Cancer & Oncology Source Type: podcasts
HOPA: promoting collaboration and engagement
Speaking from the 2018 Hematology/Oncology Pharmacy Association (HOPA) Annual Conference, held in Denver, CO, Judith Smith, PharmD, BCOP, CPHQ, FCCP, FISOPP, of UTHealth McGovern Medical School, Houst...
Author: VJOncology
Added: 08/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 29, 2018 Category: Cancer & Oncology Source Type: podcasts
NGS and high sensitivity ddPCR for detecting MRD
Speaking from the 2018 European School of Hematology (ESH) Clinical Updates on Acute Leukemias, held in Budapest, Hungary, Oliver Ottmann, MD, FRCPath, of Cardiff University, Cardiff, UK, gives an ove...
Author: VJHemOnc
Added: 08/24/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 24, 2018 Category: Cancer & Oncology Source Type: podcasts
Clinical approaches in Ph+ and Ph-like ALL
Speaking from the 2018 European School of Hematology (ESH) Clinical Updates on Acute Leukemias, held in Budapest, Hungary, Robin Fo, MD, from the University of Rome, Rome, Italy, talks about the clin...
Author: VJHemOnc
Added: 08/24/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 24, 2018 Category: Cancer & Oncology Source Type: podcasts
